When a critic says your movie could have been better summed up in a two-minute trailer, it's never a good sign.
The studio's desire to expand its Spider-Man lore is understandable according to Adam Graham of the Detroit News. Without Disney's steady hand, Sony seems to struggle to lift its villains from the comic page to the big screen.
Graham is not the only one who thinks of the film in a negative way. The film has received poor reviews across the board and recently held at 16% on the Tomatoes.
Kyle Anderson said that Morbius is a perfunctory, sloppy, paint-by-numbers attempt to remind audiences that Sony has the rights to these Spider-Man villains.
The Venom films did not have a score of more than 60 on the site, meaning they were not considered a success.
Michael Morbius is portrayed in the film by Leto, who is trying to cure himself of a rare blood disease. When an experiment goes wrong, he becomes a vampire. He craves blood even though he is seemingly cured of his disease.
He is reluctant to give in to his new urges, but his friend Milo, who also had the same blood disease and took the same cure, has few qualms about what it takes to sustain his new form.
Anderson wrote that Morbius is not good. It feels unfinished and lazy.
The movie was praised by some critics for its virtues, such as its sense of place and interest in interesting places. Leto's performance was praised by Manohla Dargis of The New York Times.
There aren't a lot of people speaking up for Morbius.
In her review of the film, Puchko wrote that the film was "tiresome."
Perhaps, the fast pacing is to make up for the lack of verve of the cast, many of whom speak in a tired tone as if they were dragged out of bed before shooting.
She said the costumes wereforgettable and the creature designs were not fresh or frightening.
According to Puchko, Morbius has little in the way of either. She warned that audiences should not expect major connections to other entities.
She wrote "Don't be fooled by the trailers that make mention of Venom, lash Spider-Man street art in the background, and tease Michael Keaton's return as The Vulture."
The full review can be found on Mashable.
Jared Leto stars as Michael Morbius in Sony’s “Morbius.”Emily Zemler wrote a review of the film for Observer.
If this were a Disney Studios property, rather than under the Sony umbrella, you would be watching this weekend on Disney+.
Zemler pointed to the lackluster special effects, one of many to say it looks like a poorly done version of the vampire prosthetics seen on the Buffy the Vampire Slayer show in the early aughts.
The lack of stakes was noted by her. Zemler wrote that the events of Spider-Man: No Way Home and the Leto flick are a pin prick.
Unless your ticket is free, don't bother.
Observer has a full review.
Charlotte O Sullivan wrote a review for The Evening Standard.
They said no. Fans shouldn't expect more. There were treats galore, O' Sullivan said. We get zilch. At press screenings, movies connected to comic book characters get a round of applause. There was actual booing at Morbius.
The script was stupider by the second, with little in the way of logic to match the leaps the film made in science or motivation. The romance between Morbius and his girlfriend Martine fails to sizzle because there are no characters or danger to care about.
Morbius feels like big chunks are missing, and my jaw dropped as I realized one particularly lackluster kerfuffle was the last battle. The final insult is a mid-credits scene featuring Michael Keaton as Adrian Toomes/Vulture. It is. Makes. No. Sense.
The full review can be found in The Evening Standard.
Somewhere in the middle of a film about a Spider-Man villain that doesn't feature Spider-Man, I was ready to jump. To move to an Alpine cottage in Switzerland and never watch a Spider-Man movie again. It is too much effort with little reward.
The film functions more as a pre-credit scene than a fully functional film. She said that the film doesn't have anything.
She wrote that the film is more frustrating than it is. I hope Sony can put up a better fight in the future.
Independent has a full review.
All Rights Reserved © 2024
